Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection-Reference-Cited by-同舟云学术

Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection

Published:2020-09-01 Issue:17 Volume:59 Page:2187-2189
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Wada Shinichi¹,Nagasaki Yoji²,Arimizu Yoko²,Shimo Masatoshi³,Matsukuma Yuta⁴,Okamoto Masaki⁵,Yoshida Shinichiro⁶,Ohashi Ikkei¹,Hashimoto Go¹,Kuwashiro Takahiro¹,Yasaka Masahiro¹,Okada Yasushi¹

Affiliation:

1. Division of Cerebrovascular Medicine and Neurology, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan

2. Division of Infectious Diseases, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan

3. Division of Hematology, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan

4. Department of Nephrology, National Hospitalization Organization, Kyushu Medical Center, Japan

5. Department of Respiratory Medicine, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan

6. Department of Emergency and Critical Care Medicine, Clinical Research Institute, National Hospitalization Organization, Kyushu Medical Center, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/17/59_5447-20/_pdf

Reference23 articles.

1. 1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet 395: 497-506, 2020.

2. 2. Yang X, Yu Y, Xu J, et al. Clinical course and outcome of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8: 475-481, 2020.

3. 3. Yousefifard M, Zali A, Mohamed Ali K, et al. Antiviral therapy in management of COVID-19: a systematic review on current evidence. Arch Acad Emerg Med 8: e45, 2020.

4. 4. Wang Z, Chen X, Lu Y, Chen F, Zhang W. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends 14: 64-68, 2020.

5. 5. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19: 383-384, 2020.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can SARS-CoV-2 trigger new onset of autoimmune disease in adults? A case-based review;Heliyon;2022-11

2. Guillain–Barré Syndrome Associated with COVID-19 in a Japanese Male;Case Reports in Neurological Medicine;2022-10-22

3. Neurological post‐acute sequelae of SARS‐CoV ‐2 infection;Psychiatry and Clinical Neurosciences;2022-10-17

4. Central nervous system outcomes of COVID-19;Translational Research;2022-03

5. COVID-19-associated Guillain–Barré syndrome in infectious period: a case report;Rinsho Shinkeigaku;2022